Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Active, closed
Ludwig-Maximilians - University of Munich
Observational
20
Munich
2024-10-06
Recruiting
Inmunova S.A.
Phase 3
220
Berlin, Cologne, Heidelberg
2024-10-05
Recruiting
Abiomed Inc.
Observational
125
Aachen, Kiel
2024-10-04
Recruiting
Akero Therapeutics, Inc
Phase 3
2,150
Frankfurt am Main, Homburg, Leipzig, Lübeck, Berlin
2024-10-04
Active, closed
AstraZeneca
Phase 3
768
Berlin-Zehlendorf, Essen, Georgsmarienhütte, Großhansdorf, Hamburg, Löwenstein, Nuremberg
2024-10-04
Recruiting
BioAegis Therapeutics Inc.
Phase 2
600
Homburg, Jena, Munich
2024-10-03
Recruiting
Zealand University Hospital
Not applicable
300
Rostock
2024-10-03
Recruiting
SoniVie Inc.
Not applicable
261
Dresden, Erlangen, Frankfurt, Freiburg im Breisgau, Hamburg, Herne, Homburg, Leipzig
2024-10-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Beelitz, Dresden, Düsseldorf, Kassel, Leipzig, Marburg, München, Münster
2024-10-02
By invitation
Paderborn University
Observational
350
Paderborn
2024-10-01
Recruiting
Edwards Lifesciences
Observational
500
Bad Berka, Bad Nauheim, Bad Neustadt an der Saale, Bad Oeynhausen, Berlin, Bonn, Dortmund, Essen
2024-10-01
Recruiting
University of Cologne
Observational
120
Cologne
2024-10-01
Recruiting
Deutsches Herzzentrum Muenchen
Not applicable
60
München
2024-10-01
Recruiting
Universitätsklinikum Köln
Observational
150
Cologne
2024-10-01
Recruiting
Technical University of Munich
Not applicable
30
München
2024-10-01
Not yet open
Charite University, Berlin, Germany
Not applicable
100
Berlin
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Leipzig
2024-10-01
Recruiting
University Hospital, Bonn
Not applicable
50
Bonn
2024-10-01
Recruiting
Göteborg University
Not applicable
324
Traben-Trarbach
2024-10-01
Recruiting
Wuerzburg University Hospital
Observational
1,834
Stuttgart, Würzburg
2024-10-01
Active, closed
Charite University, Berlin, Germany
Observational
30
Berlin
2024-10-01
Recruiting
Universitatsmedizin Mainz - 1. Medizinische Klinik
Observational
200
Mainz
2024-10-01
By invitation
Glycomine, Inc.
Phase 2
90
Münster
2024-09-30
By invitation
Sanofi
Phase 2
900
Leipzig, Mainz
2024-09-30
Active, closed
Hannover Medical School
Not applicable
20
Heidelberg, Frankfurt am Main, Hanover, Berlin
2024-09-30
Active, closed
AstraZeneca
Phase 3
310
Augsburg, Bonn, Cottbus, Hanover, Mainz
2024-09-30
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Mannheim, Ulm, Augsburg, Eggenfelden, Erlangen, München, Regensburg, Rüdersdorf
2024-09-27
Recruiting
GlaxoSmithKline
Phase 2
393
Bochum, Berlin, Kiel, Leipzig, Mainz
2024-09-27
Active, closed
BioCryst Pharmaceuticals
Phase 1
76
Heidelberg
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Ahrensburg, Bamberg, Berlin, Bonn, Coswig, Essen, Hamburg, Hanover
2024-09-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Böblingen, Homburg, Berlin, Erbach im Odenwald, Frankfurt am Main
2024-09-26
Recruiting
Hoffmann-La Roche
Observational
842
Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin
2024-09-26
Recruiting
Takeda
Observational
500
Aachen
2024-09-25
Active, closed
Longboard Pharmaceuticals
Phase 3
108
Frankfurt am Main, Bielefeld, Bonn, Kiel, Ravensburg
2024-09-25
Active, closed
Genmab
Phase 3
699
Bonn, Dortmund, Dresden, Greifswald, Hamburg, Hanover, Mannheim, München
2024-09-25
Active, closed
Lexicon Pharmaceuticals
Phase 3
500
Berlin, Hamburg, Leipzig, München
2024-09-24
By invitation
University Hospital Tuebingen
Not applicable
48
Tübingen
2024-09-24
Active, closed
Nocion Therapeutics
Phase 2
455
Munich, Darmstadt, Frankfurt am Main, Marburg, Halle, Geesthacht, Lübeck, Berlin
2024-09-24
Active, closed
Hoffmann-La Roche
Phase 3
338
Berlin, Cologne, Essen, Esslingen am Neckar, Gauting, Großhansdorf, Heidelberg, Hemer
2024-09-23
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
162
Mannheim, Wiesloch
2024-09-23
Recruiting
Zoll Medical Corporation
Observational
910
Bad Nauheim, Hanover, Cottbus, Halle
2024-09-23
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Heidelberg, Erdgeschoss, Düsseldorf
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Bonn, Göttingen, Hanover, Leipzig, Ludwigshafen am Rhein, Münster, Tübingen
2024-09-19
Recruiting
Eli Lilly and Company
Phase 1
340
Berlin, Essen, Frankfurt am Main
2024-09-19
Active, closed
argenx
Phase 3
141
Berlin, Göttingen
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Göttingen, München, Ulm, Würzburg
2024-09-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Freiburg im Breisgau, Ulm, Munich, Regensburg, Würzburg, Giessen, Buxtehude, Bochum
2024-09-18
Active, closed
Amgen
Phase 1
49
Essen, Heidelberg, Würzburg
2024-09-17
Recruiting
Pierre Fabre Medicament
Phase 1/2
171
Dresden
2024-09-17
Recruiting
University Hospital, Limoges
Not applicable
1,000
Hanover, Ulm
2024-09-17
Recruiting
Fundacio Puigvert
Observational
600
Bonn, Hamburg, Munich, Planegg, Tübingen
2024-09-17
Active, closed
Hoffmann-La Roche
Phase 3
400
Jena
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Bochum, Göttingen, Hanover, Leipzig, Ulm
2024-09-17
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
München, Cologne
2024-09-17
Recruiting
University of Erlangen-Nürnberg Medical School
Not applicable
1,250
Please Refer to Project Homepage For Details (see Link Below)
2024-09-14
Recruiting
Heart and Diabetes Center North-Rhine Westfalia
Not applicable
160
Bad Oeynhausen
2024-09-13
Recruiting
University Hospital Schleswig-Holstein
Phase 2/3
459
Dornstadt, Heidelberg, Mannheim, Ulm, Augsburg, Bamberg, Dachau, Hamburg
2024-09-12
Active, closed
Eli Lilly and Company
Phase 1
630
Berlin, Dresden, Essen, München
2024-09-12
Active, closed
Amgen
Phase 3
163
Aschaffenburg, Essen
2024-09-12
Recruiting
University Hospital Tuebingen
Not applicable
264
Tübingen
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
440
Essen, Minden, Mainz, Würzburg
2024-09-11
Active, closed
Priovant Therapeutics, Inc.
Phase 3
371
Mannheim, Bonn, Düsseldorf, Münster, Kiel, Mainz
2024-09-11
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Frankfurt am Main, Hamburg
2024-09-11
Active, closed
Noema Pharma AG
Phase 2
164
Düsseldorf, Hanover, Munich
2024-09-10
By invitation
Torsten Beyna
Observational
1,000
Düsseldorf
2024-09-10
Active, closed
GCP-Service International West GmbH
Phase 2
41
Düsseldorf, Leipzig, Münster
2024-09-10
Recruiting
University Hospital Heidelberg
Not applicable
200
Heidelberg
2024-09-09
By invitation
LMU Klinikum
Observational
108
München
2024-09-09
Active, closed
Amgen
Phase 3
315
Essen, Hösbach, Landshut, Neumünster
2024-09-09
Recruiting
University of Kiel
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
Recruiting
Steffen Paschen
Not applicable
60
Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte
2024-09-05
Recruiting
AbbVie
Phase 2
590
Freiburg im Breisgau, Mannheim, Ulm, Erlangen, Munich, Regensburg, Frankfurt am Main, Fulda
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Stuttgart, Frankfurt am Main, Cologne, Leipzig, Jena, Essen, Lübeck, Mainz
2024-09-04
Active, closed
Takeda
Phase 3
2,099
Blankenfelde-Mahlow, Bad Bentheim, Oldenburg, Dresden, Gera, Hamburg
2024-09-04
Recruiting
Aresus Pharma GmbH
Phase 3
280
Strausberg
2024-09-04
Active, closed
Tectonic Therapeutic
Phase 2
191
Mainz
2024-09-04
Recruiting
Novartis Pharmaceuticals
Observational
500
Konstanz, Stuttgart, Munich, Regensburg, Würzburg, Cottbus, Frankfurt (Oder), Ludwigshafen
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Cologne, Dresden, Giessen, Heidelberg, Munich, München, Würzburg
2024-09-03
Recruiting
4C Medical Technologies, Inc.
Not applicable
450
Berlin, Bonn, Cologne, Dortmund, Mainz, Oeynhausen, Trier, Ulm
2024-09-03
By invitation
Charite University, Berlin, Germany
Observational
60
Berlin
2024-09-02
By invitation
Amsterdam UMC, location VUmc
Not applicable
850
Bremen
2024-09-01
Recruiting
University Hospital Muenster
Observational
600
Münster
2024-09-01
Active, closed
Charite University, Berlin, Germany
Observational
932,912
Berlin
2024-09-01
Recruiting
Universitätsklinikum Hamburg-Eppendorf
Observational
184
Hamburg
2024-09-01
Recruiting
The European Forum for Research and Education in Allergy and Airway Diseases
Observational
1,000
Düsseldorf, Munich
2024-09-01
Recruiting
Charite University, Berlin, Germany
Not applicable
60
Berlin
2024-09-01
Recruiting
University of Rostock
Phase 2/3
164
Rostock
2024-09-01
Recruiting
Wuerzburg University Hospital
Observational
100
Augsburg, München, Würzburg
2024-09-01
Not yet open
University Hospital of Cologne
Not applicable
60
Cologne
2024-09-01
Recruiting
University Hospital, Bonn
Observational
100
Bonn
2024-09-01
Recruiting
University of Giessen
Not applicable
1,057
Giessen
2024-09-01
Not yet open
Odense University Hospital
Phase 2
264
Berlin
2024-09
Recruiting
Alimera Sciences
Phase 4
25
Berlin, Münster
2024-08-31
Recruiting
Dr. Inge Winter
Phase 3
418
Bielefeld, Dortmund, Frankfurt am Main, Münster
2024-08-31
Recruiting
ReAlta Life Sciences, Inc.
Phase 2
66
Freiburg im Breisgau
2024-08-31
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Aachen, Berlin, Dresden, Leipzig
2024-08-30
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Aachen, Bad Kreuznach, Bad Nenndorf, Bad Oeynhausen, Berlin, Bonn, Braunschweig, Cloppenburg
2024-08-30
Recruiting
Universitätsklinikum Hamburg-Eppendorf
Not applicable
130
Berlin, Bonn, Chemnitz, Essen, Hamburg, Hanover, Heidelberg, Lübeck
2024-08-30
Active, closed
Celgene
Phase 2
95
Regensburg, Chemnitz, Dresden
2024-08-30
Active, closed
argenx
Phase 2
33
Berlin, Dresden, Hamburg
2024-08-30
Active, closed
Central Institute of Mental Health, Mannheim
Phase 2
98
Mannheim
2024-08-29
Recruiting
TRiCares
Not applicable
80
Mainz, Munich
2024-08-29
Active, closed
Sanofi
Phase 2
229
Berlin, Halle, Mainz
2024-08-29
Recruiting
Kyverna Therapeutics
Phase 2/3
66
Berlin, Bochum, Hamburg, Hanover, Jena, Magdeburg, Munich
2024-08-28
Active, closed
AstraZeneca
Phase 2
120
Berlin, Potsdam, Ulm
2024-08-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
54
Ulm
2024-08-28
Recruiting
Bayer
Phase 3
444
Stuttgart, Nuremberg, Frankfurt am Main, Giessen, Cologne, Essen, Hemer, Berlin
2024-08-28
Active, closed
Gilead Sciences
Phase 3
640
Bad Homburg, Düsseldorf, Essen, Hamburg, Hanover, Leipzig, München, Ulm
2024-08-28
Recruiting
Prevail Therapeutics
Phase 1
124
Düsseldorf, Münster
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
204
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
132
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Recruiting
Venus MedTech (HangZhou) Inc.
Observational
200
Munich, Berlin
2024-08-26
Active, closed
Regeneron Pharmaceuticals
Phase 4
120
Augsburg, Munich, Frankfurt am Main, Koblenz, Lübeck, Berlin, Leipzig, Mainz
2024-08-26
Recruiting
University of Bonn
Observational
720
Bonn
2024-08-25
Active, closed
Kite, A Gilead Company
Phase 3
452
Berlin, Cologne, Essen, Freiburg im Breisgau, Hamburg, Leipzig, München, Tübingen
2024-08-23
Recruiting
University of Cologne
Phase 2
20
Stuttgart, Freiburg im Breisgau, Cologne, Hamburg, Essen, Berlin
2024-08-23
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
42
Aachen, Bonn, Cologne, Düsseldorf, Frankfurt, Göttingen, Hanover, Lübeck
2024-08-23
Recruiting
Nationwide Children's Hospital
Phase 2
120
Heidelberg
2024-08-22
Recruiting
AstraZeneca
Phase 2
257
Cologne, Frankfurt, Gauting, Großhansdorf, Hamburg, Heidelberg, Mainz, Münster
2024-08-22
Recruiting
Heart and Diabetes Center North-Rhine Westfalia
Not applicable
250
Bad Oeynhausen
2024-08-21
Recruiting
Abbott Medical Devices
Observational
2,500
München, Bremen, Jena, Braunschweig, Berlin, Bad Rothenfelde
2024-08-21
Recruiting
Sanofi
Phase 3
160
Berlin, Bochum, Bremen, Essen, Göttingen, Hanover, Homburg, Münster
2024-08-21
Active, closed
Pentax Medical
Observational
60
Düsseldorf
2024-08-21
Active, closed
Janssen Research & Development, LLC
Phase 2
43
Heidelberg, Tübingen, Würzburg
2024-08-20
Recruiting
Charite University, Berlin, Germany
Not applicable
273
Berlin
2024-08-19
Active, closed
AbbVie
Phase 3
699
Erlangen, Bad Bentheim, Münster, Dresden, Berlin
2024-08-19
Recruiting
Chugai Pharmaceutical
Phase 1
144
Tübingen, Erlangen, Rüdersdorf, Sachsen, Göttingen, Lübeck
2024-08-19
Recruiting
University Medical Center Goettingen
Observational
100
Göttingen
2024-08-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
90
Tübingen, Cologne, Münster, Berlin
2024-08-16
Recruiting
Charite University, Berlin, Germany
Observational
25
Hanover, Düsseldorf, Berlin
2024-08-16
Recruiting
Technical University of Munich
Observational
100
München
2024-08-15
Recruiting
Weill Medical College of Cornell University
Phase 3
700
Düsseldorf, Essen, Freiburg im Breisgau, Giessen, Jena, München, Stuttgart
2024-08-15
Active, closed
Hoffmann-La Roche
Phase 4
19
Berlin, Giessen
2024-08-14
Active, closed
Novartis Pharmaceuticals
Phase 1/2
20
Erlangen, Essen, München, Tübingen
2024-08-14
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Berlin, Dortmund, Dresden, München, Ulm
2024-08-13
By invitation
University Hospital Augsburg
Not applicable
10
Augsburg
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Berlin, Bonn, Cologne, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg
2024-08-12
Recruiting
Miltenyi Biomedicine GmbH
Phase 1/2
29
Erlangen, Magdeburg, Tübingen
2024-08-12
Recruiting
BSN Medical GmbH
Not applicable
152
Melle
2024-08-10
Recruiting
Fraunhofer-Institute of Toxicology and Experimental Medicine
Not applicable
15
Hanover
2024-08-09
Active, closed
Incyte Corporation
Phase 1
37
Aachen, Essen, Halle
2024-08-08
Recruiting
Alimentiv Inc.
Phase 4
304
Augsburg, Frankfurt am Main, Lüneburg, Kiel, Freiburg im Breisgau
2024-08-07
Recruiting
University Heart Center Freiburg - Bad Krozingen
Observational
600
Bad Krozingen, Freiburg im Breisgau, Nuremberg, Villingen-Schwenningen
2024-08-07
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Frankfurt, Hanover, München, Münster
2024-08-07
Recruiting
AstraZeneca
Phase 3
1,018
Berlin, Deggendorf, Düsseldorf, Göttingen, Hamburg, Heidelberg, Jena, Karlsruhe
2024-08-07
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
210
Heidelberg, Erdgeschoss, Düsseldorf
2024-08-07
Recruiting
Innoventric LTD
Not applicable
25
Mainz, Leipzig
2024-08-05
Active, closed
Novartis Pharmaceuticals
Phase 2
84
Kirchheim unter Teck, Munich, Ludwigshafen, Berlin, Mainz
2024-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Essen, Dresden, Hohenmölsen, Bad Berka, Berlin
2024-08-05
Recruiting
Technische Universität Dresden
Observational
200
Dresden
2024-08-05
Recruiting
Hannah Schaefer
Observational
100
Munich
2024-08-05
Recruiting
Nationwide Children's Hospital
Observational
350
Heidelberg
2024-08-02
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Not applicable
40
Hamburg
2024-08-01
Recruiting
Technical University of Munich
Not applicable
50
Munich
2024-08-01
Recruiting
Dr. Inge Winter
Phase 4
418
Augsburg, Bielefeld, Dortmund, Frankfurt am Main, Mainz, Münster
2024-08-01
By invitation
Buchinger Wilhelmi Development & Holding GmbH
Observational
300
Überlingen
2024-08-01
Active, closed
InSightec
Not applicable
67
Kiel
2024-08-01
Active, closed
Harald Gündel
Not applicable
375
Ulm, Magdeburg, Berlin
2024-08-01
By invitation
University Hospital, Bonn
Not applicable
12
Bonn
2024-08-01
Recruiting
Firalis SA
Observational
4,100
Lübeck, Mainz-GE
2024-08-01
Active, closed
GlaxoSmithKline
Phase 3
10,212
Weinheim, Dachau, Munich, Hanover, Cologne, Essen, Goch, Freiberg
2024-08-01
Recruiting
AstraZeneca
Phase 3
788
Aachen, Augsburg, Berlin, Cologne, Dessau, Düsseldorf, Erlangen, Göttingen
2024-08-01
Recruiting
University of Giessen
Not applicable
150
Giessen
2024-08-01
Recruiting
Zentralklinik Bad Berka
Observational
5,000
Bad Berka
2024-08-01
Recruiting
Wuerzburg University Hospital
Observational
200
Würzburg, Jena
2024-08-01
By invitation
University Hospital Goettingen
Observational
100
Göttingen
2024-08
Recruiting
University Medical Center Groningen
Phase 3
300
Berlin, Cologne, Dresden, Leipzig
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Berlin, Giessen, Halle, Heidelberg, Löwenstein, Oldenburg
2024-07-31
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Essen, Bottrop, Dresden, Leipzig, Mönchengladbach, München, Münster, Wolfsburg
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Munich, Regensburg, Würzburg, Frankfurt am Main, Bochum, Essen
2024-07-31
By invitation
AOP Orphan Pharmaceuticals AG
Observational
110
Berlin, Dresden, Greifswald
2024-07-31
By invitation
Wuerzburg University Hospital
Not applicable
64
Würzburg
2024-07-31
Recruiting
University Medical Center Goettingen
Observational
50
Göttingen
2024-07-30
Recruiting
University Medical Center Goettingen
Observational
75
Göttingen
2024-07-30
By invitation
Viatris Innovation GmbH
Phase 3
680
Leipzig, Minden
2024-07-30
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Freiburg im Breisgau, Kehl, Ulm, Erlangen, München, Bernau bei Berlin, Marburg, Osnabrück
2024-07-30
Active, closed
Annexon, Inc.
Phase 3
659
Neubrandenburg, Münster, Bonn, Heidelberg, Tübingen
2024-07-30
Active, closed
Novartis Pharmaceuticals
Phase 1
31
München, Rostock
2024-07-29
Active, closed
UCB Biopharma SRL
Phase 3
89
Berlin, Frankfurt am Main, Freiburg im Breisgau
2024-07-29
Recruiting
AstraZeneca
Observational
300
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus
2024-07-25
Recruiting
University of Kiel
Not applicable
42
Kiel
2024-07-25
Recruiting
Universität Münster
Observational
257
Münster
2024-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Heidelberg, Heilbronn, Schwäbisch Hall, Munich, Marburg, Düsseldorf, Essen, Worms
2024-07-24
Active, closed
Ferrer Internacional S.A.
Phase 2
241
Beelitz, Düsseldorf, Leipzig, Munich
2024-07-23
Recruiting
Medtronic Cardiac Ablation Solutions
Observational
1,950
Frankfurt, Heidelberg, Ludwigshafen am Rhein, Paderborn
2024-07-23
Active, closed
OncoVerity, Inc.
Phase 2
140
Düsseldorf, Frankfurt, Kiel
2024-07-22
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Aachen, Cologne, Homburg, Münster
2024-07-22
Active, closed
MedSIR
Phase 2
165
Bottrop, Essen, Hamburg, München
2024-07-22
Recruiting
Wave Life Sciences USA, Inc.
Phase 1/2
48
Aachen
2024-07-19
Active, closed
University Hospital Tuebingen
Not applicable
120
Tübingen
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Freiburg im Breisgau, Heidelberg, Tübingen, München, Frankfurt am Main, Hanover, Dresden, Lübeck
2024-07-19
Recruiting
Hazem Omran
Observational
200
Bad Oeynhausen
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Aachen, Bad Bentheim, Berlin, Bonn, Dresden, Düsseldorf, Essen, Hamburg
2024-07-19
Recruiting
GlaxoSmithKline
Phase 3
150
Bonn, Frankfurt
2024-07-19
Recruiting
Fresenius Medical Care Deutschland GmbH
Not applicable
46
Aschaffenburg, Munich, Braunschweig, Paderborn, Berlin, Ulm, Würzburg
2024-07-18
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Berlin, Dachau, Duisburg, Frankfurt am Main, Halle, Heidelberg, Kiel, Leipzig
2024-07-18
Recruiting
Amgen
Phase 3
450
Berlin, Chemnitz, Dresden, Essen, Frankfurt am Main, Hamburg, Ludwigsburg, München
2024-07-17
Recruiting
Hannover Medical School
Not applicable
756
Ludwigsburg, Tübingen, Bad Homburg, Göttingen, Hanover, Lüneburg, Bielefeld, Düsseldorf
2024-07-17
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Immenhausen, Essen, Großhansdorf, Esslingen am Neckar, Giessen, Hamburg, Hemer, Neuss
2024-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Landshut, Hanover, Aachen, Essen, Mainz, Halle, Jena, Berlin
2024-07-16
Recruiting
Heidelberg University
Observational
4,000
Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen, Heidelberg, Kiel
2024-07-16
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Cologne, Essen, Hanover, Heilbronn, Karlsruhe, Mülheim, Neumünster, Rendsburg
2024-07-15
Recruiting
Pamgene International B.V.
Observational
196
Tübingen, Heidelberg, München
2024-07-12
Recruiting
Philogen S.p.A.
Phase 2
162
Essen, Freiburg im Breisgau, Kiel, Tübingen
2024-07-12
Active, closed
Sanofi
Phase 3
109
Bad Homburg, Berlin, Bochum, Essen, Giessen, Tübingen
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Langenau, Darmstadt, Löhne, Dülmen, Kiel, Berlin, Bramsche, Mainz
2024-07-11
Recruiting
Replimune, Inc.
Phase 3
400
Berlin, Dresden, Erfurt, Essen, Hamburg, Heidelberg, Kiel, Mainz
2024-07-11
Recruiting
AO Innovation Translation Center
Observational
76
Freiburg im Breisgau, Münster
2024-07-10
Recruiting
University Hospital Tuebingen
Phase 1
52
Tübingen
2024-07-10
Recruiting
Bielefeld University
Not applicable
40
Bielefeld, Marburg
2024-07-09
Recruiting
Marc Donath
Phase 2
300
Düsseldorf
2024-07-09
Recruiting
Servier Bio-Innovation LLC
Phase 3
156
Bad Saarow, Berlin, Dresden, Hamburg, Mannheim, München, Münster, Ulm
2024-07-09
Recruiting
AbbVie
Phase 3
40
Sankt Augustin, Berlin, Hamburg
2024-07-08
Recruiting
Universitätsklinikum Hamburg-Eppendorf
Observational
60
Hamburg
2024-07-08
Recruiting
University Hospital Tuebingen
Not applicable
120
Stuttgart
2024-07-08
Recruiting
University of Freiburg
Phase 3
400
Freiburg im Breisgau
2024-07-07
Active, closed
Amgen
Phase 3
89
Essen
2024-07-05
Recruiting
Istituto Giannina Gaslini
Observational
200
Heidelberg
2024-07-04
Recruiting
University Hospital, Basel, Switzerland
Not applicable
498
Bad Krozingen, Bad Nauheim, Bad Oeynhausen, Giessen, Kiel
2024-07-04
Recruiting
AO Innovation Translation Center
Observational
600
Frankfurt, Giessen, Heidelberg, Münster, Wildeshausen
2024-07-03
Recruiting
Aesculap AG
Observational
140
Ulm
2024-07-03
Active, closed
University of Ulm
Not applicable
399
Aachen, Berlin, Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen
2024-07-02
Recruiting
University Hospital Muenster
Observational
100
Münster
2024-07-02
Recruiting
Jena University Hospital
Observational
74
Jena
2024-07-01
Recruiting
University Hospital, Bonn
Observational
1,200
Bonn, Mannheim
2024-07-01
Recruiting
University Hospital Tuebingen
Not applicable
60
Tübingen
2024-07-01
Active, closed
Johannes Gutenberg University Mainz
Not applicable
1,354
Homburg, Mainz
2024-07-01
Recruiting
University Hospital Tuebingen
Not applicable
50
Tübingen
2024-07-01
Recruiting
European Foundation for Study of Chronic Liver Failure
Phase 2
90
Aachen, Münster
2024-07-01
Recruiting
TheraOp
Phase 2
110
Dresden, Essen, Freiburg im Breisgau, Göttingen, Homburg, Mönchengladbach, München, Oldenburg
2024-07-01
Not yet open
Technische Universität Dresden
Phase 2
276
Freiburg im Breisgau, Heidelberg, Mannheim, Würzburg, Dresden, Leipzig, Berlin, München
2024-07-01
Recruiting
Deutsches Herzzentrum Muenchen
Not applicable
666
Heidelberg, Mannheim, Singen, Ulm, Augsburg, Dachau, Erding, Ingolstadt
2024-07-01
Recruiting
University Hospital, Basel, Switzerland
Observational
15,000
Bad Berka, Bad Krozingen, Cottbus, Münster
2024-07-01
Recruiting
University Hospital, Bonn
Observational
300
Bonn
2024-07-01
Recruiting
Cardioangiologisches Centrum Bethanien
Observational
200
Berlin, Frankfurt am Main
2024-07-01
Recruiting
Technical University of Munich
Not applicable
120
Munich
2024-07-01
Not yet open
European Society of Anaesthesiology
Observational
8,250
Düsseldorf
2024-06-30
Active, closed
AstraZeneca
Phase 3
339
Berlin, Bochum, Dresden, Erlangen, Essen, Freiburg im Breisgau, Hanover, Kiel
2024-06-29
Recruiting
AstraZeneca
Observational
600
Bad Homburg, Berlin, Bremen, Celle, Chemnitz, Cologne, Deggendorf, Frankfurt
2024-06-28
Recruiting
argenx
Phase 2/3
12
Essen
2024-06-28
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Freiburg im Breisgau, Würzburg, Berlin, Herne
2024-06-28
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Aachen, Greifswald, Halle, Rostock
2024-06-28
Recruiting
Intensity Therapeutics, Inc.
Phase 3
333
Bad Saarow, Leipzig
2024-06-28
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Dresden, Erlangen, Essen, Hamburg, Mannheim, Ulm
2024-06-28
Recruiting
IRCCS Sacro Cuore Don Calabria di Negrar
Not applicable
278
Hamburg
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Freiburg im Breisgau, Tübingen, Erlangen, Memmingen, Darmstadt, Bad Bentheim, Rostock, Bochum
2024-06-27
Recruiting
Infertility Treatment Center Dortmund
Observational
2,400
Dortmund
2024-06-26
Recruiting
University Hospital Tuebingen
Observational
50
Bonn, Mannheim, München, Münster, Siegen, Tübingen, Ulm
2024-06-26
Recruiting
Stemline Therapeutics, Inc.
Observational
80
Augsburg, Bielefeld, Chemnitz, Frankfurt, Freiburg im Breisgau, Halle, Hamburg, Kiel
2024-06-26
Active, closed
Genmab
Phase 3
621
Berlin, Dresden, Essen, Giessen, Greifswald, Hanover, Leipzig, München
2024-06-25
Active, closed
UCB Biopharma SRL
Phase 3
176
Bad Bentheim, Berlin, Bonn, Dresden, Erlangen, Frankfurt am Main, Hamburg, Kiel
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Recruiting
AstraZeneca
Observational
1,850
Würzburg, Frankfurt am Main, Hanover, Aachen, Cologne, Mainz, Homburg, Berlin
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Ulm, Göttingen, Hanover, Bochum, Düsseldorf, Dresden, Leipzig, Lübeck
2024-06-25
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
20
Erlangen
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Freiburg im Breisgau, Ludwigsburg, Tübingen, Erlangen, Munich, Potsdam, Georgsmarienhütte, Hanover
2024-06-24
Recruiting
University of Freiburg
Observational
220
Freiburg im Breisgau
2024-06-24
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
132
Bad Hersfeld
2024-06-21
Recruiting
Heinrich-Heine University, Duesseldorf
Observational
77
Düsseldorf
2024-06-20
Recruiting
University Medical Center Goettingen
Observational
500
Göttingen
2024-06-20
Active, closed
Max Planck Social Neuroscience Lab
Not applicable
200
Berlin
2024-06-20
Recruiting
AstraZeneca
Phase 3
240
Bad Nauheim, Berlin, Bonn, Freiburg im Breisgau, Herne, München, Tübingen
2024-06-20
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Heidelberg, Mannheim, Tübingen, Regensburg, Bonn, Chemnitz, Leipzig, Berlin
2024-06-19
Active, closed
Celgene
Phase 3
850
Ulm, Augsburg, Bayreuth, Erlangen, Langen, Hanover, Koblenz, Halle
2024-06-19
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
München, Ulm
2024-06-19
Recruiting
University Hospital Freiburg
Not applicable
50
Freiburg im Breisgau
2024-06-18
Recruiting
Otto-von-Guericke University Magdeburg
Not applicable
20
Magdeburg
2024-06-18
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
10
Erlangen
2024-06-18
Active, closed
AbbVie
Phase 1
60
Frankfurt am Main, Cologne, Hamburg
2024-06-17
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Cologne, Magdeburg
2024-06-17
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Aachen, Bad Friedrichshall, Berlin, Bonn, Dessau, Dresden, Erfurt, Frankfurt
2024-06-17
Active, closed
University of Glasgow
Observational
2,000
Giessen
2024-06-15
Active, closed
Paris Translational Research Center for Organ Transplantation
Observational
5,000
Berlin
2024-06-15
Recruiting
Heinrich-Heine University, Duesseldorf
Observational
150
Düsseldorf
2024-06-15
Active, closed
Hannover Medical School
Phase 4
44
Hanover
2024-06-14
Recruiting
ABX advanced biochemical compounds GmbH
Phase 3
434
Dresden, Düsseldorf, Gronau, Hamburg, Leipzig, München, Münster, Rostock
2024-06-13
Recruiting
Gilead Sciences
Phase 1/2
334
Berlin, Cologne
2024-06-12
Active, closed
Novartis Pharmaceuticals
Observational
116
Hamburg, Lingen, Koblenz, Leipzig, Halle, Ahaus, Berlin, Bremen
2024-06-11
Active, closed
AskBio Inc
Phase 2
59
Berlin, Marburg, Tübingen, Würzburg
2024-06-11
Recruiting
University Hospital Tuebingen
Phase 1
20
Tübingen
2024-06-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Dortmund, Essen, Lübeck, Gera, Berlin
2024-06-10
Recruiting
LEO Pharma
Phase 3
195
Buxtehude, Dresden, Mainz, Osnabrück, Tübingen, Wuppertal
2024-06-10
Active, closed
GlaxoSmithKline
Phase 3
88
Hamburg
2024-06-10
Recruiting
Dr. Falk Pharma GmbH
Phase 2
356
Mainz
2024-06-10
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Chemnitz, Hamburg, Heidelberg, Würzburg
2024-06-07
Active, closed
Exelixis
Phase 2/3
600
Giessen
2024-06-07
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Amberg, Bamberg, Berlin, Bremen, Chemnitz, Düsseldorf, Frankfurt, Freiburg im Breisgau
2024-06-07
Active, closed
GlaxoSmithKline
Phase 4
302
Mainz, Herne, Lübeck, Meerbusch
2024-06-06
Recruiting
X4 Pharmaceuticals
Phase 3
176
Dresden
2024-06-06
Recruiting
University Hospital, Basel, Switzerland
Phase 2
75
Freiburg im Breisgau, Würzburg
2024-06-06
Recruiting
Boris Böll
Observational
400
Cologne, Dessau, Essen, Frankfurt am Main, Leipzig, Magdeburg
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Pforzheim, München, Ulm, Hanover, Lüneburg, Rostock, Cologne, Duisburg
2024-06-05
Recruiting
Immunocore Ltd
Phase 3
680
Berlin, Bremen, Dortmund, Dresden, Erfurt, Erlangen, Essen, Frankfurt
2024-06-05
Active, closed
Amgen
Phase 3
563
Cologne, Dresden, Essen, Gauting, Großhansdorf, Heidelberg, Münster, Würzburg
2024-06-05
Recruiting
University Hospital Tuebingen
Observational
300
Tübingen, Essen
2024-06-04
Recruiting
Eli Lilly and Company
Phase 3
300
Cologne, Leipzig, Ulm
2024-06-03
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Düsseldorf, Freiburg im Breisgau, Halle, Hamburg, Hanover, Heidelberg, Jena, Kiel
2024-06-03
Recruiting
Lohmann & Rauscher
Observational
110
Berlin, Mannheim, Munich, Münster, Rheine, Tübingen
2024-06-03
Recruiting
University Hospital, Bordeaux
Not applicable
192
München
2024-06-03
Recruiting
Curasight
Phase 2
168
Chemnitz, Düsseldorf, Hamburg, Munich
2024-06-01
Recruiting
University Hospital Tuebingen
Observational
225
Tübingen
2024-06-01
Recruiting
University Hospital, Essen
Not applicable
30
Essen
2024-06-01
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
100
Erlangen
2024-06-01
Recruiting
Jena University Hospital
Observational
228
Tübingen, Ulm, München, Hanover, Bonn, Dresden, Leipzig, Halle
2024-06-01
Recruiting
Wuerzburg University Hospital
Not applicable
52
Würzburg
2024-06-01
Recruiting
Semmelweis University
Observational
1,000
Freiburg im Breisgau, Mainz, Tübingen
2024-06-01
Recruiting
University of Giessen
Observational
400
Bad Nauheim, Giessen
2024-05-31
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Freiburg im Breisgau
2024-05-30
Active, closed
Stealth BioTherapeutics Inc.
Phase 3
313
Münster, Regensburg, Tübingen
2024-05-30
Active, closed
Amgen
Phase 1/2
94
Essen, Frankfurt am Main, Freiburg im Breisgau, Leipzig
2024-05-30
Active, closed
Hoffmann-La Roche
Phase 4
21
Berlin, Giessen
2024-05-30
Active, closed
Amgen
Phase 1
120
Essen, Heidelberg, Würzburg
2024-05-29
By invitation
Deutsches Herzzentrum Muenchen
Observational
250
Munich
2024-05-28
Recruiting
Philipps University Marburg
Not applicable
40
Marburg
2024-05-28
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Essen
2024-05-28
Recruiting
Hoffmann-La Roche
Phase 3
1,800
Chemnitz, Frankfurt, Freiburg im Breisgau, Hanover, Homburg, Münster
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Stuttgart, Greifswald, Bielefeld, Solingen
2024-05-24
Active, closed
Ludwig-Maximilians - University of Munich
Not applicable
150
Munich
2024-05-24
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Bayreuth, Böblingen, Erbach im Odenwald, Ulm
2024-05-24
Recruiting
University of Cologne
Phase 2
120
Cologne
2024-05-24
Active, closed
Fresenius Medical Care Deutschland GmbH
Observational
60
Aschaffenburg, Würzburg, Berlin
2024-05-22
By invitation
University of Bonn
Not applicable
80
Bonn
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Cologne, Leipzig
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Berlin, Erfurt, Essen, Frankfurt, Frankfurt am Main, Gauting, Gera, Giessen
2024-05-21
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
220
Heidelberg, Tübingen, Munich, Berlin, Hamburg
2024-05-20
Recruiting
Vedanta Biosciences, Inc.
Phase 3
852
Frankfurt am Main, Cologne, Berlin
2024-05-20
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Berlin, Essen, Heidelberg
2024-05-20
Active, closed
AbbVie
Phase 3
421
Freiburg im Breisgau, Karlsruhe, Chemnitz, Berlin, Frankfurt am Main, Hamburg
2024-05-19
Active, closed
Heinrich-Heine University, Duesseldorf
Observational
55
Düsseldorf
2024-05-17
Recruiting
Advanced Bionics AG
Not applicable
102
Freiburg im Breisgau
2024-05-15
Recruiting
Bayer
Observational
50,000
Berlin
2024-05-15
Recruiting
Boehringer Ingelheim
Phase 2
175
Bonn, Mainz, Neubrandenburg, Tübingen, Ulm
2024-05-15
Active, closed
Novartis Pharmaceuticals
Phase 1
42
Essen, München
2024-05-15
Active, closed
University Hospital, Basel, Switzerland
Observational
2,000
Augsburg, Düsseldorf, Essen, Heidelberg, Lübeck
2024-05-15
Recruiting
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
53
Bad Oeynhausen, Berlin, Bremen, Hamburg, Heidelberg, Leipzig, Würzburg
2024-05-14
Active, closed
Biotronik AG
Not applicable
1,861
Neuss
2024-05-13
Recruiting
University Hospital, Bonn
Not applicable
90
Bonn
2024-05-13
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Freiburg im Breisgau, Kehl, Ulm, Erlangen, Bernau bei Berlin, Marburg, Osnabrück, Bielefeld
2024-05-13
Not yet open
Charite University, Berlin, Germany
Phase 2
110
Berlin
2024-05-10
Recruiting
University Hospital, Essen
Observational
400
Essen
2024-05-08
Active, closed
Pfizer
Observational
360
Freiburg im Breisgau, Kassel, Aachen, Andernach, Berlin, Cologne, Dachau, Frankfurt am Main
2024-05-08
Recruiting
Technical University of Munich
Phase 4
2,252
Munich, Hanover, Dresden
2024-05-08
Recruiting
University of Ulm
Not applicable
80
Ulm
2024-05-08
Active, closed
Sanofi
Phase 3
1,541
Augsburg, Bad Bentheim, Hamburg, Kiel, Mainz, Münster, Witten
2024-05-08
Recruiting
PSC Partners Seeking a Cure
Observational
2,000
Hamburg
2024-05-06
Recruiting
Miltenyi Biomedicine GmbH
Not applicable
40
Berlin, Cologne, Erlangen, Göttingen, Münster, Tübingen, Würzburg
2024-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Heidelberg, Göttingen, Dresden, Kiel, Berlin, Hamburg
2024-05-03
Recruiting
Technical University of Munich
Observational
100
München
2024-05-02
Active, closed
Hoffmann-La Roche
Phase 2
256
Berlin, München
2024-05-02
By invitation
University of Modena and Reggio Emilia
Observational
500
Munich
2024-05-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lübeck, Berlin, Bonn, Göttingen, Hamburg, Heidelberg, Leipzig, Mannheim
2024-05-01
Recruiting
Weizmann Institute of Science
Observational
40
Hamburg
2024-05-01
Recruiting
Montreal Heart Institute
Observational
21,000
Hamburg, Mainz
2024-05-01
Recruiting
University Medical Center Goettingen
Observational
700
Göttingen
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bad Nauheim, Bad Oeynhausen, Berlin, Bremen, Dortmund, Dresden, Elsterwerda, Essen
2024-04-30
Recruiting
Sven Behrendt
Not applicable
40
Dortmund
2024-04-30
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Hamburg, Leipzig, Münster
2024-04-30
Recruiting
Hemovent GmbH
Observational
60
Hanover, Essen, Halle, Erfurt
2024-04-30
Recruiting
University Hospital Tuebingen
Phase 2
60
Tübingen, Jena
2024-04-29
Active, closed
Apogee Therapeutics, Inc.
Phase 2
470
Freiburg im Breisgau, Heidelberg, Tübingen, Augsburg, München, Blankenfelde-Mahlow, Darmstadt, Frankfurt am Main
2024-04-29
Recruiting
Eli Lilly and Company
Phase 3
510
Berlin, Dresden, Frankfurt am Main, Jena, Lübeck, Sachsen
2024-04-29
Recruiting
AstraZeneca
Phase 3
582
Berlin, Cologne, Erfurt, Frankfurt, Göttingen, Immenhausen, Kiel, Mainz
2024-04-29
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Ulm
2024-04-29
Recruiting
CSL Behring
Phase 2/3
3,110
Berlin, Hessen, Kaiserslautern, Kiel, Leipzig, Mainz, Villingen-Schwenningen
2024-04-27
Active, closed
Eli Lilly and Company
Phase 3
450
Berlin, Dresden, Frankfurt am Main, Heidelberg, Marburg, Weisbaden
2024-04-26
Active, closed
AstraZeneca
Observational
831
Aachen, Alsfeld, Bamberg, Bechhofen, Bergisch Gladbach, Berlin, Brilon, Bruchsal
2024-04-25
Recruiting
IHF GmbH - Institut für Herzinfarktforschung
Not applicable
224
Berlin, Bonn, Essen, Halle, Heidelberg, Hemer, Immenhausen, Langen
2024-04-24
Active, closed
Puerta de Hierro University Hospital
Not applicable
390
Hanover
2024-04-24
Recruiting
CentroDerm GmbH
Not applicable
20
Wuppertal
2024-04-23
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Essen, Leipzig, Stuttgart
2024-04-22
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Düsseldorf, Jena
2024-04-22
Active, closed
Amgen
Phase 3
111
Cologne, Würzburg
2024-04-22
Recruiting
Simon Jäger
Observational
77
Stuttgart, Munich, Nuremberg, Löwenstein
2024-04-19
Recruiting
Stephanie Gräger
Not applicable
80
Jena
2024-04-19
Recruiting
University Hospital Heidelberg
Phase 2/3
80
Heidelberg
2024-04-19
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Berlin, Braunschweig, Cologne, Dresden, Frankfurt am Main, Hamburg, Herne, Jena
2024-04-18
Recruiting
University of Ulm
Not applicable
150
Ulm
2024-04-17
Recruiting
University of Leipzig
Phase 2
140
Mannheim, Ulm, München, Regensburg, Würzburg, Potsdam, Cologne, Leipzig
2024-04-17
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Augsburg, Berlin, Dachau, Frankfurt, Göttingen, Halle, Hanover, Kiel
2024-04-17
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
24
Augsburg, Berlin, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, München
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 3
44
Munich, Berlin
2024-04-17
Active, closed
Sanofi
Phase 3
2,500
Bayreuth, Berlin, Bochum, Dresden, Düsseldorf, Essen, Giessen, Hamburg
2024-04-16
Active, closed
argenx
Phase 3
119
Berlin, Bochum, Würzburg
2024-04-16
Recruiting
University Hospital, Bonn
Observational
300
Bonn
2024-04-15
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
Berlin, Cologne, Freiburg im Breisgau, Greifswald, Halle, Kiel, Münster, Stuttgart
2024-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Erlangen, München, Potsdam, Georgsmarienhütte, Düsseldorf, Essen, Saarbrücken, Gera
2024-04-14
By invitation
Intellia Therapeutics
Observational
100
Berlin
2024-04-12
Active, closed
Celldex Therapeutics
Phase 2
140
Augsburg, Bad Bentheim, Berlin, Bochum, Erlangen, Frankfurt, Heidelberg, Münster
2024-04-12
Active, closed
German Institute of Human Nutrition
Not applicable
30
Potsdam
2024-04-12
Recruiting
AstraZeneca
Phase 3
3,850
Bad Nauheim, Bechhofen, Berlin, Bernau bei Berlin, Chemnitz, Coburg, Dresden, Elsterwerda
2024-04-12
Recruiting
AstraZeneca
Phase 3
675
Berlin, Bonn, Cologne, Düsseldorf, Essen, Freiburg im Breisgau, Gauting, Georgsmarienhütte
2024-04-11
Active, closed
University Hospital Tuebingen
Phase 2
107
Augsburg, Cologne, Frankfurt, Freiburg im Breisgau, Leipzig, Mannheim, Munich, Regensburg
2024-04-10
Recruiting
Daiichi Sankyo
Phase 1/2
680
Heidelberg, Heilbronn, Münster, Mainz, Dresden, Leipzig, Berlin
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Stuttgart, Munich, Dresden, Jena, Berlin, Hamburg
2024-04-10
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
24
Göttingen
2024-04-10
Recruiting
German Federal Institute for Risk Assessment
Observational
6,000
Karlsruhe, Jena, Berlin, Bonn, Giessen, Heidelberg, Regensburg
2024-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Cologne, Halle, Leverkusen, Lübeck, Mettmann, München
2024-04-09
Active, closed
Amgen
Phase 3
434
Heidelberg, Bad Doberan, Greifswald Hansestadt, Chemnitz, Hamburg
2024-04-08
Recruiting
Technische Universität Dresden
Phase 2
146
Essen, Aachen, Augsburg, Chemnitz, Cologne, Dresden, Erlangen, Frankfurt am Main
2024-04-07
Recruiting
Marc Bosiers, MD
Observational
109
Berlin, Frankfurt, Göttingen, Heidelberg, Lünen, Münster, Regensburg, Stuttgart
2024-04-05
Active, closed
University of Heidelberg Medical Center
Phase 3
411
Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Braunschweig, Chemnitz
2024-04-05
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Essen, München
2024-04-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Esslingen am Neckar, Regensburg, Hemer, Koblenz, Leipzig, Halle, Bad Berka, Gera
2024-04-03
Active, closed
Avalyn Pharma Inc.
Phase 2
398
Munich, München, Rosenheim, Hanover, Frankfurt, Essen, Mainz, Leipzig
2024-04-03
Recruiting
Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression
NCT06396312Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms, Depressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms), Depressive Disorder, Major, Recurrent, With Psychotic Symptoms, Depressive Disorder, Major, Recurrent, Without Psychotic Symptoms
Max-Planck-Institute of Psychiatry
Observational
130
Munich
2024-04-02
Active, closed
Gaia AG
Not applicable
328
Hamburg
2024-04-02
Recruiting
Hoffmann-La Roche
Phase 4
320
Cologne, Essen, Karlsruhe, Mannheim, Ulm
2024-04-02
Recruiting
University Medical Center Goettingen
Observational
32
Goettigen
2024-04-01
By invitation
University Hospital, Bonn
Observational
400
Munich, Bonn
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Recruiting
Technische Universität Dresden
Not applicable
200
Dresden, Halle, Leipzig
2024-04-01
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
140
Mannheim
2024-04-01
Recruiting
University Hospital Augsburg
Not applicable
2,000
Augsburg
2024-04-01
Recruiting
University of Bonn
Observational
50
Bonn
2024-04-01
Recruiting
LMU Klinikum
Not applicable
180
Munich
2024-04-01
Recruiting
University Hospital Heidelberg
Not applicable
30
Heidelberg
2024-04-01
Not yet open
Jena University Hospital
Not applicable
300
Jena, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Halle, Homburg
2024-04-01
Active, closed
Takeda
Phase 2
213
Frankfurt am Main, Hamburg, Heidelberg, Kiel, Ludwigshafen, Tübingen, Ulm
2024-03-29
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
584
Aachen, Berlin, Erlangen, Essen, Greifswald, Hanover, Mainz, München
2024-03-29
Recruiting
Splice Bio
Observational
75
Bonn, Tübingen
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Aachen, Amberg, Bad Oeynhausen, Berlin, Bochum, Dresden, Essen, Falkensee
2024-03-29
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Essen, Magdeburg, Düsseldorf, Erlangen, München
2024-03-28
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Munich, Regensburg, Dresden, Halle, Berlin
2024-03-28
Active, closed
Gilead Sciences
Phase 2
228
Dresden, Halle, Kiel, Ulm
2024-03-27
Recruiting
Karolinska Institutet
Not applicable
1,022
Bamberg, Freiburg im Breisgau, Halle, Kandel
2024-03-27
Recruiting
International Research Training Group 2804
Observational
100
Tübingen
2024-03-26
Recruiting
Italfarmaco
Phase 3
220
Mannheim, Dresden, Halle, Hamburg
2024-03-26
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
330
Aachen, Berlin, Frankfurt am Main, Hanover, Jena, Mannheim, München
2024-03-26
Recruiting
University Hospital Goettingen
Phase 3
102
Heidelberg, München, Hamburg, Frankfurt am Main, Göttingen, Cologne, Münster, Leipzig
2024-03-25
Active, closed
Gilead Sciences
Phase 3
577
Aachen, Berlin, Cologne, Frankfurt, Hamburg, Munich, München
2024-03-25
Active, closed
AbbVie
Phase 2
156
Ulm, Munich, Ludwigshafen am Rhein, Leipzig, Kiel, Hamburg
2024-03-23
Recruiting
Molecure S.A.
Phase 2
96
Essen, Freiburg im Breisgau, Mainz-GE
2024-03-21
Recruiting
GlaxoSmithKline
Phase 3
864
Augsburg, Berlin, Erlangen, Essen, Giessen, Hamburg, Neuruppin, Straubing
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
336
Aachen, Bonn, Darmstadt, Frankfurt, Hohenstein-Ernsttal, Schleswig
2024-03-20
Recruiting
Charite University, Berlin, Germany
Not applicable
140
Berlin
2024-03-20
Recruiting
Aesculap AG
Observational
132
Frankfurt am Main
2024-03-19
Recruiting
Verastem, Inc.
Phase 3
270
Frankfurt am Main, Berlin, Dresden, Essen, Hamburg, Mannheim, Ulm
2024-03-18
Active, closed
University of Ulm
Not applicable
31
Ulm
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Bochum, Cologne, Erlangen, Essen, Heidelberg, Leipzig, Munich, Regensburg
2024-03-15
By invitation
Abbott Medical Devices
Not applicable
1,500
Dortmund, Bad Nauheim, Cologne, Frankfurt, Kiel, München, Ulm
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Berlin, Freiburg im Breisgau, Sankt Augustin
2024-03-14
Recruiting
Technische Universität Dresden
Observational
500
Aachen, Chemnitz, Dresden, Düsseldorf, Essen, Göttingen, Hamburg, Jena
2024-03-13
Recruiting
WALA Heilmittel GmbH
Phase 3
350
Mannheim
2024-03-13
Recruiting
Hoffmann-La Roche
Phase 3
1,350
Chemnitz, Frankfurt am Main, Freiburg im Breisgau, Hanover, Homburg, Münster
2024-03-13
Recruiting
Medical University Innsbruck
Not applicable
1,350
Essen, Freiburg im Breisgau, Giessen, Jena
2024-03-12
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Düsseldorf, Halle, Moers, Neuss
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Munich, Cologne, Aachen, Augsburg, Berlin, Essen, Münster, Rostock
2024-03-12
Recruiting
Lohmann & Rauscher
Observational
208
Aachen, Brüggen, Dortmund, Erlangen, Hamburg, Mönchengladbach, Waidhaus, Willich
2024-03-11
Recruiting
Leiden University Medical Center
Not applicable
3,280
Dresden, Düsseldorf, Tübingen
2024-03-11
Active, closed
Edward Geissler
Phase 4
322
Aachen, Berlin, Bochum, Dresden, Hamburg, Hanover, Jena, Mainz
2024-03-09
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Augsburg, Bad Bentheim, Berlin, Bochum, Darmstadt, Dresden, Dülmen, Düsseldorf
2024-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Frankfurt am Main, Kaiserslautern, Dresden, Leipzig, Ahaus, Berlin, Bonn, Essen
2024-03-07
Recruiting
Universität Duisburg-Essen
Not applicable
118
Bamberg
2024-03-06
Recruiting
University of Cologne
Phase 2
29
Cologne
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aachen, Bad Friedrichshall, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2024-03-05
Active, closed
Fresenius Kabi SwissBioSim GmbH
Observational
600
Berlin, Halle, Ludwigsfelde, Magdeburg, Naumburg, Planegg, Potsdam, Templin
2024-03-05
Recruiting
Takeda
Phase 2
268
Frankfurt, Frankfurt am Main, Kiel, Ludwigshafen, Mannheim, Tübingen, Ulm
2024-03-05
Recruiting
University Hospital, Essen
Observational
10,000
Essen
2024-03-05
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Munich, Ulm
2024-03-04
Active, closed
AstraZeneca
Phase 3
594
Berlin, Frankfurt, Göttingen, Hamburg, Heidelberg, Heilbronn, Leipzig, Marburg
2024-03-04
Recruiting
Catholic University of Applied Sciences Mainz
Not applicable
150
Bad Kreuznach, Meisenheim
2024-03-04
Recruiting
University of Erlangen-Nürnberg Medical School
Not applicable
12
Erlangen
2024-03-04
Recruiting
Technische Universität Dresden
Observational
180
Dresden
2024-03-02
Not yet open
Universitätsklinikum Hamburg-Eppendorf
Observational
148
Hamburg
2024-03-01
Active, closed
University Hospital Ulm
Observational
240,000
Ulm, Munich
2024-03-01
Recruiting
University of Zurich
Observational
75
Heidelberg, Munich
2024-03-01
Recruiting
Takeda
Phase 3
50
Aachen, Berlin, Hanover, Tübingen
2024-03-01
Recruiting
University Hospital Heidelberg
Phase 2
30
Heidelberg
2024-03-01
Recruiting
University Hospital Muenster
Observational
2,000
Chemnitz, Aachen, Greifswald, Leipzig, Münster, Tübingen
2024-03-01
By invitation
Christian Dorfer
Observational
100
Berlin, Tübingen
2024-03-01
Recruiting
icometrix
Observational
7,000
Bochum, Berlin
2024-03-01
Recruiting
Amsterdam UMC
Not applicable
654
Mainz
2024-03-01
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
102
Mannheim
2024-03-01
Active, closed
41medical AG
Observational
60
Münster, Siegen
2024-02-29
Recruiting
University of Bonn
Observational
50
Bonn
2024-02-29
Recruiting
University of Erlangen-Nürnberg Medical School
Not applicable
148
Erlangen
2024-02-29
Active, closed
Sanofi
Phase 3
464
Berlin, Blankenfelde-Mahlow, Dresden, Frankfurt, Lübeck, Witten
2024-02-29
Active, closed
Acumen Pharmaceuticals
Phase 2
542
Berlin, Cologne, Mannheim, Munich
2024-02-29
Recruiting
Heidelberg University
Not applicable
304
Berlin, Düsseldorf, Heidelberg, Jena, Ulm
2024-02-28
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Freiburg im Breisgau, Munich, Regensburg, Weiden in Der Oberpfalz, Langen, Bergisch Gladbach, Essen, Mönchengladbach
2024-02-28
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Essen, Kiel
2024-02-28
Recruiting
Daiichi Sankyo
Phase 2/3
860
Dresden, Essen, Hamburg, Mannheim, Ulm
2024-02-27
Active, closed
Terumo Europe N.V.
Not applicable
50
Heilbronn, Tübingen
2024-02-27
Recruiting
Heidelberg University
Not applicable
60
Heidelberg
2024-02-27
Recruiting
Larry Hinkson
Not applicable
356
Berlin
2024-02-27
Recruiting
Daiichi Sankyo
Phase 2
740
Frankfurt
2024-02-26
Recruiting
Aleksander Krag
Phase 3
240
Berlin, Jena, Münster
2024-02-26
Recruiting
Christian S. Meyhoff
Observational
100
Hamburg
2024-02-26
Recruiting
University Medical Center Goettingen
Observational
150
Göttingen
2024-02-23
Recruiting
Pulmonx Corporation
Not applicable
200
Essen, Halle, Hamburg, Heidelberg, Hemer
2024-02-22
Active, closed
AstraZeneca
Phase 2
142
Berlin, Cologne, Großhansdorf, Moers, Würzburg
2024-02-22
Recruiting
University Hospital Tuebingen
Observational
160
Tübingen
2024-02-21
Recruiting
University Hospital Augsburg
Observational
500
Augsburg
2024-02-21
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Halle, Bonn, Esslingen am Neckar, Frankfurt a.M., Gauting, Großhansdorf, Heidelberg
2024-02-21
Recruiting
University Hospital Tuebingen
Observational
30
Tübingen
2024-02-21
Active, closed
ViiV Healthcare
Phase 3
463
Frankfurt am Main, Berlin, Cologne, Hamburg, München
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
München
2024-02-20
Recruiting
Jena University Hospital
Phase 3
616
Freiburg im Breisgau, Heidelberg, Tübingen, Augsburg, München, Nuremberg, Regensburg, Rosenheim
2024-02-20
Active, closed
Novo Nordisk A/S
Phase 2
88
Heidelberg, München, Münster, Würzburg
2024-02-20